×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
APYX – apyx medical corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
APYX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
05:23 am
apyx
Cold Plasma Research Report 2024-2025 & 2029: North America Leads Global Cold Plasma Market; Asia Pacific to See Highest Growth [Yahoo! Finance]
Medium
Report
Cold Plasma Research Report 2024-2025 & 2029: North America Leads Global Cold Plasma Market; Asia Pacific to See Highest Growth [Yahoo! Finance]
3/25
09:16 am
apyx
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener" [Yahoo! Finance]
Medium
Report
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener" [Yahoo! Finance]
3/25
09:00 am
apyx
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Medium
Report
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
3/13
09:48 am
apyx
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
3/13
07:00 am
apyx
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
Low
Report
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
2/27
08:00 am
apyx
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025
Medium
Report
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/13
04:06 pm
apyx
Form 10-K Apyx Medical Corp For: Dec 31
Medium
Report
Form 10-K Apyx Medical Corp For: Dec 31
3/13
07:01 am
apyx
Form 8-K Apyx Medical Corp For: Mar 13
Low
Report
Form 8-K Apyx Medical Corp For: Mar 13
3/3
04:05 pm
apyx
Form 4/A Apyx Medical Corp For: Aug 13 Filed by: HILL MATTHEW C
Medium
Report
Form 4/A Apyx Medical Corp For: Aug 13 Filed by: HILL MATTHEW C
2/14
04:35 pm
apyx
Form SCHEDULE 13G Apyx Medical Corp Filed by: Nantahala Capital Management, LLC
Neutral
Report
Form SCHEDULE 13G Apyx Medical Corp Filed by: Nantahala Capital Management, LLC
2/6
04:14 pm
apyx
Form 8-K Apyx Medical Corp For: Jan 31
Medium
Report
Form 8-K Apyx Medical Corp For: Jan 31
1/17
04:07 pm
apyx
Form 4 Apyx Medical Corp For: Jan 15 Filed by: Vizirgianakis Stavros G.
High
Report
Form 4 Apyx Medical Corp For: Jan 15 Filed by: Vizirgianakis Stavros G.
1/17
04:07 pm
apyx
Form 4 Apyx Medical Corp For: Jan 15 Filed by: CITRONOWICZ MOSHE
High
Report
Form 4 Apyx Medical Corp For: Jan 15 Filed by: CITRONOWICZ MOSHE
1/17
04:07 pm
apyx
Form 4 Apyx Medical Corp For: Jan 15 Filed by: Levine Wendy Lauren
High
Report
Form 4 Apyx Medical Corp For: Jan 15 Filed by: Levine Wendy Lauren
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/7
Form 10-Q Apyx Medical Corp For: Jun 30
15.2%
11/11 Apyx Medical Corporation Reports Third Quarter of 2019 Financial Results and Updates Fiscal Year 2019 Outlook 14.3%
3/17 Apyx Medical Corp (NASDAQ: APYX) had its price target lowered by analysts at Piper Sandler from to . 11.7%
12/3 Form 8-K Apyx Medical Corp For: Dec 03 8.3%
5/4 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm Before June 17 8.1%
5/8 Q1/2019 3/31/2019 EPS -0.140 ZacksConsensus -0.190 ActVsEst 0.050 - Beat 8.0%
3/25 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX 7.6%
3/23 APYX MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corporation on Behalf of Stockholders and Encourages Investors to Contact the Firm 6.8%
8/10 Apyx Medical Corp (APYX) CEO Charlie Goodwin on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.7%
7/1 Apyx Medical Corporation Joins Russell 3000® and Russell 2000® Indexes 3.4%
11/11 Apyx Medical Corporation Reports Third Quarter of 2019 Financial Results and Updates Fiscal Year 2019 Outlook 14.3%
3/17 Apyx Medical Corp (NASDAQ: APYX) had its price target lowered by analysts at Piper Sandler from to . 11.7%
12/3 Form 8-K Apyx Medical Corp For: Dec 03 8.3%
5/4 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm Before June 17 8.1%
5/8 Q1/2019 3/31/2019 EPS -0.140 ZacksConsensus -0.190 ActVsEst 0.050 - Beat 8.0%
3/25 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX 7.6%
3/23 APYX MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corporation on Behalf of Stockholders and Encourages Investors to Contact the Firm 6.8%
8/10 Apyx Medical Corp (APYX) CEO Charlie Goodwin on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.7%
7/1 Apyx Medical Corporation Joins Russell 3000® and Russell 2000® Indexes 3.4%
TOP News Decliners
3/13
APYX MEDICAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Apyx Medical Corporation - APYX
-17.1%
3/19 INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Apyx Medical Corporation and Encourages Investors with Losses to Contact the Firm -9.9%
8/5 Apyx Medical Corporation Receives 510(k) Clearance for Next-Generation J-Plasma® Precise Handpiece Designed for Laparoscopic Surgery -9.9%
4/12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX -9.6%
3/20 ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -8.1%
11/29 Global Intraoperative Neuromonitoring Market Outlook 2018 & 2019-2027 -6.8%
3/17 Equity Alert: Rosen, a Globally Recognized Firm, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -6.4%
8/22 Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October -5.9%
11/14 Apyx Medical Corp (NASDAQ: APYX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.75 price target on the stock. -5.9%
3/5 Form 4 Apyx Medical Corp For: Jan 10 Filed by: Swandal Craig A. -5.7%
3/19 INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Apyx Medical Corporation and Encourages Investors with Losses to Contact the Firm -9.9%
8/5 Apyx Medical Corporation Receives 510(k) Clearance for Next-Generation J-Plasma® Precise Handpiece Designed for Laparoscopic Surgery -9.9%
4/12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX -9.6%
3/20 ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -8.1%
11/29 Global Intraoperative Neuromonitoring Market Outlook 2018 & 2019-2027 -6.8%
3/17 Equity Alert: Rosen, a Globally Recognized Firm, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -6.4%
8/22 Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October -5.9%
11/14 Apyx Medical Corp (NASDAQ: APYX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.75 price target on the stock. -5.9%
3/5 Form 4 Apyx Medical Corp For: Jan 10 Filed by: Swandal Craig A. -5.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: